Original Article
Neuropsychopharmacology (2006) 31, 2443–2448. doi:10.1038/sj.npp.1301076; published online 12 April 2006
Preclinical Research
Effects of Antidepressants on the Brain/Plasma Distribution of Corticosterone
Claudia-Carolin Weber1, Gunter P Eckert1 and Walter E Müller1
1Department of Pharmacology, Biocenter (ZAFES), University of Frankfurt, Frankfurt, Germany
Correspondence: Professor Dr WE Müller, Department of Pharmacology, Biocenter (ZAFES), Marie-Curie Strasse 9, 60439 Frankfurt, Germany, Tel: +49 69 79829373; Fax: +49 69 79829374; E-mail: PharmacolNat@em.uni-frankfurt.de
Received 11 August 2005; Revised 13 February 2006; Accepted 7 March 2006; Published online 12 April 2006.
Abstract
It is well established that hypothalamic–pituitary–adrenal (HPA) axis dysregulation, characterized by elevated circulating cortisol concentrations and impaired negative feedback inhibition, is associated with affective disorders. As normalization of the HPA axis function and mood-stabilizing effects occur simultaneously during antidepressant treatment, it is likely that these effects are either directly or indirectly dependent. Although data concerning the outward transport of glucocorticoids from the brain by P-glycoprotein (Pgp) are inconsistent, it has been hypothesized that antidepressants exert their clinical activity in parts by inhibiting Pgp, subsequently leading to enhanced brain glucocorticoid levels and the normalization of the HPA axis function. Here, we report on the effects of different antidepressants (amitriptyline, fluoxetine, mirtazapine, St John's wort extract) on the brain/plasma distribution of corticosterone in mice after acute and subchronic treatment. The four antidepressants exerted different effects on the corticosterone concentration in brain and plasma. Changes in corticosterone levels were highly correlated, suggesting passive diffusion between both tissues. St John's wort extract and fluoxetine elevated brain and plasma corticosterone concentrations after subchronic treatment. Mirtazapine and amitriptyline had no effect on corticosterone concentration after subchronic treatment, possibly because both are also potent antagonists at the 5-HT2 receptor, which mediates HPA axis stimulation by serotonergic stimuli. In addition, St John's wort is the only antidepressant tested which slightly elevated Pgp protein level in the brain.
Keywords:
P-glycoprotein, St John's wort extract, corticosterone, glucocorticoids, depression, antidepressants
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
New approaches to antidepressant drug discovery: beyond monoamines
Nature Reviews Neuroscience Review (01 Feb 2006)
RESEARCH
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Molecular Psychiatry Original Article

